Gastrointestinal follicular lymphoma: review of the literature.
スポンサーリンク
概要
- 論文の詳細を見る
Gastrointestinal follicular lymphoma (GI-FL) is a relatively rare disease, accounting for only 1%-3.6% of gastrointestinal non-Hodgkin's lymphoma. Although the duodenum and terminal ileum are considered to be the most common sites of origin, the development of wireless capsule endoscopy and double-balloon enteroscopy has increased the detection of GI-FL in every part of the small intestine. Approximately 70% of patients with GI-FL are estimated to have multiple lesions throughout the entire gastrointestinal tract. FL is a low-grade lymphoma that usually develops very slowly. If the lymphoma causes no symptoms, immediate treatment may not be necessary. Standard therapy has not yet been established for GI-FL, but chemotherapy, radiotherapy, monoclonal antibody therapy, or a combination of these therapies, is sometimes performed based on the therapeutic regimens for nodal FL. Regimens including conventional chemotherapy with rituximab, which achieve high response rates in nodal FL, are commonly used for GI-FL. The long-term clinical outcome of GI-FL is unclear. The results of a few series on the long-term outcomes of patients with GI-FL treated with conventional therapy indicate a median relapse-free time ranging from 31 to 45 months. On the other hand, in patients with GI-FL who were followed without treatment, the median time to disease progression was 37.5 months. Thus, whether to initiate aggressive therapy or whether to continue watchful waiting in patients with GI-FL is a critically important decision. Ongoing research on biomarkers to guide individualized GI-FL therapy may provide invaluable information that will lead to the establishment of a standard therapeutic regimen.
論文 | ランダム
- 知的財産権に関する国際私法原則(日韓共同提案原案)--2010年8月21日版の解説 (特集 金融制度改革) -- (日韓比較・国際知的財産法研究(7))
- コンテンツ産業の構造・市場の変化と新たな知的財産権保護及び活用
- グローバルビジネスロー研修基礎セミナー 国際知的財産法研修基礎講座(第12回)知的財産権に関する国際裁判管轄と準拠法(2)
- 海外情報 中国発(第2回)知的財産権問題の奥にあるもの
- Anhydriteのカソードルミネセンスに及ぼす試料温度効果